Correction to: Dapagliflozin: A Review in Type 2 Diabetes

被引：0
|
作者：
Sohita Dhillon
机构：
[1] Springer Nature,
来源：
Drugs | 2019年 / 79卷 / 18期
关键词：
D O I：
10.1007/s40265-019-01239-1
中图分类号：
学科分类号：
摘要：
The article Dapagliflozin: A Review in Type 2 Diabetes, written by Sohita Dhillon
引用
收藏
页码：2013 / 2013
相关论文
共 50 条
  • [41] Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
    Johnston, Rhona
    Uthman, Olalekan
    Cummins, Ewen
    Clar, Christine
    Royle, Pamela
    Colquitt, Jill
    Tan, Bee Kang
    Clegg, Andrew
    Shantikumar, Saran
    Court, Rachel
    O'Hare, J. Paul
    McGrane, David
    Holt, Tim
    Waugh, Norman
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (02) : 1 - +
  • [42] Blood Pressure Reduction Effect of Dapagliflozin in Patients with Type 2 Diabetes Mellitus: a Systematic Review
    Lee, J. V.
    Sabran, M. Z.
    Rubismo, K. Y.
    Zebua, A.
    Jhoputri, C. F.
    Lee, J. B.
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 (SUPPL 2)
  • [43] DAPAGLIFLOZIN, AN SGLT2 INHIBITOR FOR THE TREATMENT OF TYPE 2 DIABETES
    Demaris, K. M.
    White, J. R.
    [J]. DRUGS OF TODAY, 2013, 49 (05) : 289 - 301
  • [44] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Donald Elliott Kohan
    Paola Fioretto
    Kristina Johnsson
    Shamik Parikh
    Agata Ptaszynska
    Lisa Ying
    [J]. Journal of Nephrology, 2016, 29 : 391 - 400
  • [45] Dapagliflozin: An emerging treatment option for type 2 diabetes mellitus
    Lu, Jessica
    Ta, Elisa
    Song, Jessica C.
    [J]. FORMULARY, 2011, 46 (10) : 412 - +
  • [46] Dapagliflozin Lowers Blood Pressure in Patients with Type 2 Diabetes
    Sjostrom, David
    Ptaszynska, Agata
    List, James F.
    Johnsson, Eva
    [J]. DIABETES, 2014, 63 : A613 - A613
  • [47] EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD
    Abdullaev, Sherzod
    Sharapov, Olimkhon
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I685 - I686
  • [48] Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes
    Mulder, Skander
    Heerspink, Hiddo J. L.
    Darshi, Manjula
    Kim, Jiwan J.
    Laverman, Gozewijn D.
    Sharma, Kumar
    Pena, Michelle J.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2422 - 2428
  • [49] The effect of dapagliflozin on renal function in patients with type 2 diabetes
    Kohan, Donald Elliott
    Fioretto, Paola
    Johnsson, Kristina
    Parikh, Shamik
    Ptaszynska, Agata
    Ying, Lisa
    [J]. JOURNAL OF NEPHROLOGY, 2016, 29 (03) : 391 - 400
  • [50] Safety of dapagliflozin in clinical trials for type 2 diabetes mellitus
    Johnsson, K.
    Ptaszynska, A.
    Apanovitch, A.
    Sugg, J. E.
    Parikh, S. J.
    List, J. F.
    [J]. DIABETOLOGIA, 2012, 55 : S304 - S304
12345